Header Gradient
News
FDA Warns of Infection Risk from Repackaged Avastin Injections

FDA Warns of Infection Risk from Repackaged Avastin Injections

The U.S. Food and Drug Administration (FDA) is alerting health care professionals that repackaged intravitreal injections of Avastin (bevacizumab) have caused a cluster of serious eye infections in the Miami, Florida area.

The Florida Department of Health (DOH) notified FDA of a cluster of Streptococcus endophthalmitis infections in three clinics following intravitreal injection of repackaged Avastin.  Investigators traced the tainted injections to a single pharmacy located in Hollywood, Florida.   The pharmacy repackaged the Avastin from sterile injectable 100 mg/4 mL, single-use, preservative-free vials into individual 1 mL single-use syringes.

Read the FDA report.